Indian stocks: Visit www.stage2stocks.com →

Intercure Ltd.

Stage 2 · Advancing · week 9

As of Oct 22, 2026, Intercure is in Stage 2, the uptrend phase, now in week 9 (since Aug 26, 2026). It closed at $4.44, 41.2% below its 52-week high and below its 200-day average, which is falling.

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. More about the company

$4.44
+0.45% today
$66.6M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 26 in Drug Manufacturers - Specialty & Generic · #1 of 272 in Health Care

Is INCR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 21w
S2 16w
S4 18w
S4 29w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 21w → S1 8w → S2 16w → S3 12w → S4 18w → S1 8w → S4 11w → S1 7w → S4 2w → S2 10w → S3 1w → S4 29w → S1 13w → S2 8w current
Total tracked: 166 weeks across 14 stage runs.

INCR among Drug Manufacturers - Specialty & Generic53rd of 84 by relative strength

All 84 →
Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CPIXStage 2 · wk 2398+6.8%
2ETONStage 2 · wk 3097−10.1%
3ANIKStage 2 · wk 1596+3.5%
4IRWDStage 3 · wk 396−16.4%
5TEVAStage 2 · wk 995+3.1%
6AMRXStage 2 · wk 1995+5.9%
7KNSAStage 2 · wk 7395+6.2%
8AMLXStage 2 · wk 1593−6.6%
…53INCRStage 2 · wk 928−18.8%
vs 52W High
-41.2%
$3.65 lo$7.55 hi
41.2% below 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 9
1w13w26w
Week 9, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
-4.2%
200 DMA: $4.63 · sloping down
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.13x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-18.8%
3M
-8.1%
6M
-1.2%
YTD
-13.8%
1Y
-40.4%
Scan Membership
Breakout Watch
Latest: 2024-03-07
4 appearances in last 60 days. First seen: 2020-06-23.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 9 · Vol 0.13x
2026-10-21S2
Wk 8 · Vol 0.18x
2026-10-20S2
Wk 8 · Vol 0.09x
2026-10-19S2
Wk 8 · Vol 0.07x
2026-10-16S2
Wk 8 · Vol 0.19x
2026-10-15S2
Wk 8 · Vol 0.22x
2026-10-14S2
Wk 7 · Vol 0.35x
2026-10-13S2
Wk 7 · Vol 0.26x
2026-10-12S2
Wk 7 · Vol 0.25x
2026-10-09S2
Wk 7 · Vol 0.02x
2026-10-08S2
Wk 7 · Vol 0.12x
2026-10-07S2
Wk 6 · Vol 0.29x
Moving averages & range
50 DMA
$5.13
200 DMA
$4.63
52W High
$7.55
52W Low
$3.65
5D Low
$4.42
Resistance levels (recent highs)
20d High
$5.45
60d High
$5.95
120d High
$6.00
250d High
$7.55
Next resistance
+22.7%
to 20d High
ROE
-9.3%
Profit margin -13.2%
Dividend Yield
0.00%
P/B 0.6

Intercure: quick answers

What stage is Intercure in?

As of Oct 22, 2026, Intercure (INCR) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 26, 2026 and is in week 9. What the four stages mean

Is Intercure in an uptrend?

Yes. Intercure is in a Stage 2 uptrend. It trades 4.2% below its 200-day average, which is falling.

How far is Intercure from its 52-week high?

Intercure closed at $4.44 on Oct 22, 2026, 41.2% below its 52-week high of $7.55. Its 52-week low is $3.65.

How has Intercure performed over the past year?

As of Oct 22, 2026, Intercure is down 40.4% over the past year and down 13.8% so far in 2026.

Which sector and industry is Intercure in?

Intercure is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.